Antimicrobial stewardship in Latin America: Past, present, and future.
Journal
Antimicrobial stewardship & healthcare epidemiology : ASHE
ISSN: 2732-494X
Titre abrégé: Antimicrob Steward Healthc Epidemiol
Pays: England
ID NLM: 9918266096106676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
02
2022
revised:
16
03
2022
accepted:
21
03
2022
entrez:
9
12
2022
pubmed:
10
12
2022
medline:
10
12
2022
Statut:
epublish
Résumé
Implementation of antimicrobial stewardship programs (ASPs) in well-resourced countries has been associated with reductions in antibiotic-resistant infections and improved patient outcomes. Several guidance documents providing recommendations on how to structure antimicrobial stewardship activities at the national and hospital level in resource-limited settings have been published. However, few hospitals in Latin America report having a structure or resources needed for a successful ASP. Given the alarming increases in antimicrobial resistance in Latin America, better understanding of barriers to promote implementation of effective ASPs is urgently needed. We have summarized past and present antimicrobial stewardship activities in Latin American hospitals, and we describe key elements needed in future efforts to strengthen antimicrobial stewardship in the region.
Identifiants
pubmed: 36483374
doi: 10.1017/ash.2022.47
pii: S2732494X2200047X
pmc: PMC9726506
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e68Informations de copyright
© The Author(s) 2022.
Références
MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31
pubmed: 26247436
J Hosp Infect. 2014 Mar;86(3):161-8
pubmed: 24534705
Clin Infect Dis. 2018 Aug 1;67(4):525-532
pubmed: 29790913
Clin Infect Dis. 1997 Sep;25(3):584-99
pubmed: 9314444
J Gen Intern Med. 2020 Apr;35(4):1182-1188
pubmed: 31630364
Infect Control Hosp Epidemiol. 2022 Feb;43(2):181-190
pubmed: 33829982
Rev Panam Salud Publica. 2020 Sep 23;44:e68
pubmed: 32973908
Rev Panam Salud Publica. 2011 Dec;30(6):667-8
pubmed: 22358421
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
BMJ Qual Saf. 2022 Mar;31(3):199-210
pubmed: 34099497
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
J Chemother. 2009 Nov;21(5):527-34
pubmed: 19933044
Clin Infect Dis. 2003 Jul 15;37(2):180-6
pubmed: 12856209
Braz J Infect Dis. 2016 May-Jun;20(3):255-61
pubmed: 27094234
Clin Microbiol Infect. 2016 Sep;22(9):812.e9-812.e17
pubmed: 27373529
Clin Infect Dis. 2018 Sep 28;67(8):1168-1174
pubmed: 29590355
Crit Care Res Pract. 2014;2014:480463
pubmed: 25525515
JAMA Netw Open. 2021 Feb 1;4(2):e210235
pubmed: 33635327
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1301-1304
pubmed: 31524120
Health Hum Rights. 2018 Jun;20(1):67-77
pubmed: 30008553
J Am Board Fam Med. 2018 May-Jun;31(3):417-430
pubmed: 29743225
BMC Health Serv Res. 2019 Mar 25;19(1):189
pubmed: 30909897
Int J Infect Dis. 2021 Jul;108:13-17
pubmed: 33932602
Int J Qual Health Care. 2019 Nov 30;31(9):704-711
pubmed: 31198929
Rev Panam Salud Publica. 2021 Jul 26;45:e76
pubmed: 34322161
BMJ Glob Health. 2019 Sep 11;4(5):e001730
pubmed: 31565417
Antibiotics (Basel). 2020 Aug 12;9(8):
pubmed: 32806754
Infect Control Hosp Epidemiol. 2017 Jun;38(6):756-758
pubmed: 28366177
Infect Control Hosp Epidemiol. 2019 May;40(5):579-584
pubmed: 30786944
J Antimicrob Chemother. 2015 Apr;70(4):1245-55
pubmed: 25527272